CNTN2 and adult T-cell leukemia/lymphoma: To investigate the clinical and immunological features of long‐term survivors with complete remission of newly diagnosed aggressive‐type ATLL that was treated with intensive chemotherapy with and without mogamulizumab, we analyzed the T lymphocytes of these patients, with a focus on HTLV‐1 Tax‐specific CTLs.